St. Petersburg State Pavlov Medical University
Clinical trials sponsored by St. Petersburg State Pavlov Medical University, explained in plain language.
-
New drug cocktail aims to make risky transplants safer for blood cancer patients
Disease control Recruiting nowThis study tests a new combination of drugs (bendamustine and cyclophosphamide) to prevent graft-versus-host disease and a dangerous immune reaction after stem cell transplants. It involves 60 adults with high-risk blood cancers who have a partially matched donor. The goal is to …
Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New immunotherapy combo takes on standard chemo for hodgkin lymphoma
Disease control Recruiting nowThis study tests whether a new combination of the immunotherapy drug nivolumab plus chemotherapy (AVD) works better and is safer than the standard BEACOPP-like chemotherapy for people with advanced Hodgkin lymphoma. About 178 adults aged 18-60 with newly diagnosed stage IIB, III,…
Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC